Waters Corporation Stock Drops 3.16% Amid $17.5 Billion Merger Announcement, Trading Volume Plummets to 489th Position

On July 18, 2025, Waters Corporation (WAT) experienced a significant decline in its stock price, dropping by 3.16%. The trading volume for the day was 2.07 billion, marking a 32.16% decrease from the previous day. This placed Waters at the 489th position in terms of trading volume for the day.

Waters Corporation and BD's Biosciences & Diagnostic Solutions Business have agreed to merge, creating a leading entity in the life science and diagnostics sector. This strategic move is aimed at enhancing capabilities in regulated, high-volume testing. The merger is valued at $17.5 billion, with BD receiving $4 billion in cash and a 39.2% stake in the combined company. This partnership is expected to drive significant growth and innovation in the diagnostics industry.

Following the merger announcement, Waters Corporation's stock price experienced a dip. The merger is part of a broader strategy to build a high-volume diagnostics leader, focusing on regulated testing solutions. This move is anticipated to strengthen Waters' position in the market and enhance its diagnostic capabilities.